BioInsights - Vol 4 Issue 11

CELL & GENE THERAPY INSIGHTS

November 2018 Issue

Vol 4 Issue 11

Featuring

Issue Spotlights: Strategies for Scale-up & Scale-out | Scale-Out and -Up Strategies
Other articles
Webinar

SPOTLIGHT

Strategies for Scale-up & Scale-out
Prof Nik Willoughby
Guest Editor:
Prof Nik Willoughby

Editorial

Critical considerations for allogeneic cell therapy scale up

Critical considerations for allogeneic cell therapy scale up

Sharon Grimster
18 December 2018
Read

Research Article

Scale-up of a perfusion-based dendritic cell generation process

Scale-up of a perfusion-based dendritic cell generation process

A Kozbial, H Weinstein, S Murthy et al.
18 December 2018
Read

Expert Insight

The long road to affordability: a cost of goods analysis for an autologous CAR-T process

The long road to affordability: a cost of goods analysis for an autologous CAR-T process

Katy Spink, Andrew Steinsapir
18 December 2018
Read
Back to the future: where are we taking lentiviral vector manufacturing?

Back to the future: where are we taking lentiviral vector manufacturing?

Hanna P Lesch
18 December 2018
Read
Translating cell and gene therapies to the clinic

Translating cell and gene therapies to the clinic

H Dave, D Saunders, N Zhang et al.
18 December 2018
Read

Innovator Insight

Commercial Lessons for Clinical Success

Commercial Lessons for Clinical Success

S Ellison, H Hagen, C Suchet
19 December 2018
Read

Interview

Biopharma scale-up lessons to learn for cell & gene therapy

Biopharma scale-up lessons to learn for cell & gene therapy

Nik Willoughby
8 January 2019
Read
Towards commercial allogeneic cell therapy manufacturing

Towards commercial allogeneic cell therapy manufacturing

Maria Del Pilar Redondo
18 December 2018
Read
Autologous T cell immunotherapy scale out manufacturing models – the biotech perspective

Autologous T cell immunotherapy scale out manufacturing models – the biotech perspective

Nina Kotsopoulou
18 December 2018
Read

SPOTLIGHT

Scale-Out and -Up Strategies

Expert Insight

Scale-up of lentiviral vectors for gene therapy: advances and challenges

Scale-up of lentiviral vectors for gene therapy: advances and challenges

A McCarron, M Donnelley, D Parsons
16 November 2017
Read

Interview

Approaches and challenges for the manufacture and scale-out of autologous cell therapies

Approaches and challenges for the manufacture and scale-out of autologous cell therapies

Richard Harrison
16 November 2017
Read

Journal articles

Research Article

Methylcellulose as a scaffold in the culture of liver-organoids for the potential of treating acute liver failure

Methylcellulose as a scaffold in the culture of liver-organoids for the potential of treating acute liver failure

A Chandrashekran, V Iansante, A Dhawan et al.
18 December 2018
Read

Expert Insight

Management of ‘out of specification’ commercial autologous CAR-T cell products

Management of ‘out of specification’ commercial autologous CAR-T cell products

Alexey Bersenev, Sven Kili
17 December 2018
Read

Webinars